A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Alpha Butyl Olopatadine - Request Quote

Picture of Alpha Butyl Olopatadine

Alpha Butyl Olopatadine

SZ CAT No:SZ-O007016
CAS No
NA
Mol.F.
C25H31NO3
Mol.Wt.
393.5
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Alpha Butyl Olopatadine is chemically 2-{(11Z)-11-[3-(dimethylamino)propylidene]-6,11-dihydrodibenzo[b,e]oxepin-2-yl} hexanoic acid. Alpha Butyl Olopatadine is supplied with detailed characterization data compliant with regulatory guideline. Alpha Butyl Olopatadine can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Olopatadine.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Alpha Butyl Olopatadine

Purchase Alpha Butyl Olopatadine

Alpha Butyl Olopatadine suppliers

Alpha Butyl Olopatadine manufacturers

Alpha Butyl Olopatadine price

Order Alpha Butyl Olopatadine

Enquire Alpha Butyl Olopatadine

Alpha Butyl Olopatadine cost

Alpha Butyl Olopatadine Supplier

Alpha Butyl Olopatadine Distributor

Alpha Butyl Olopatadine for Method Validation

Olopatadine Reference Standard

Alpha Butyl Olopatadine for ANDA Filing

Alpha Butyl Olopatadine for Forced Degradation Studies

Alpha Butyl Olopatadine Identification Standards

Alpha Butyl Olopatadine for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,